Our difference

Innovation is one of the strongest values of the Imagine Institute. Demonstrating its expertise, relying on the knowledge and experience of every doctor and researcher there, the Institute is dedicated to generating new ideas, new treatments or new diagnostic methods, through the spirit of exchange and interaction encouraged by the place.

The goal is to share knowledge gathered in research to clinical practice, and develop new solutions. These close links between research and clinical practice will help the emergence of new lines of research, and thus new treatments. Theory and practice, reflection and application are thus combined.

At the service of the patient

This continuity between Research and Medical Care is supported by a patient-centered organization. The Imagine Institute takes a "loop" approach, from the patient to research and from research to the patient, to speed up progress in research and find new treatments more speedily.

Genetic diseases affect very many patients, but individually are actually rather rare. All too often, medicine is powerless in a number of cases that cannot be diagnosed or cured. Imagine's strength lies in bringing together in one place many specialists in different fields of genetic disease, both researchers and clinicians, as well as providing access to a large and detailed patient database, thus improving understanding of the causes and mechanisms of these illnesses.

Any attempt to cure a genetic disease first requires defining the genes responsible, characterizing their mutations and finally understanding the way they cause vital cells to malfunction (in the nervous system, muscles, skin, blood, etc.).
These three stages lie at the heart of the Imagine Institute's research and are decisive in the initiation of a treatment.

Over the last twenty years, doctors and researchers have identified the genetic and molecular bases of over 200 diseases, contributing to cellular and genetic therapies, as well as to developing prenatal and pre-implantation diagnostics, two excellent methods for screening for genetic diseases before birth. Within the Institute, our teams developed the first test available in the world for gene therapy to treat hereditary immune deficiency, a historical achievement.